Youcare Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings
Youcare Pharmaceutical Group Co., Ltd. is an integrated enterprise engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The organization focuses on therapeutic areas such as cardiovascular and cerebrovascular diseases, digestive health, anti-infectives, and endocrine disorders. Its portfolio includes chemical drugs, modern traditional Chinese medicines, and biological preparations, with notable products like Ginkgo Biloba Extract Injection. The company maintains a comprehensive industrial chain, covering the production of active pharmaceutical ingredients and finished dosage forms. By prioritizing technological innovation and quality control, the group provides medical solutions to clinical and retail sectors. Its operations are supported by large-scale production bases and a dedicated research infrastructure aimed at developing both high-end generic and innovative medications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于投资建设项目的公告 | 2026-05-07 | Chinese | |
| 关于自愿披露子公司YKYY018雾化吸入剂治疗与预防人偏肺病毒感染的适应症获得FDA临床试验批准的公告 | 2026-03-24 | Chinese | |
| 中信证券股份有限公司关于悦康药业集团股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查意见 | 2026-03-20 | Chinese | |
| 中信证券股份有限公司关于悦康药业集团股份有限公司部分募投项目变更及结项暨将节余募集资金用于新增募投项目及永久补充流动资金的核查意见 | 2026-03-20 | Chinese | |
| 2025年度独立董事述职报告（陈可冀）（届满离任） | 2026-03-20 | Chinese | |
| 2025年度募集资金存放与实际使用情况鉴证报告 | 2026-03-20 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44267085 | 关于投资建设项目的公告 | 2026-05-07 | Chinese | ||
| 39253874 | 关于自愿披露子公司YKYY018雾化吸入剂治疗与预防人偏肺病毒感染的适应症获得FDA临床试验批准的公告 | 2026-03-24 | Chinese | ||
| 39253862 | 中信证券股份有限公司关于悦康药业集团股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查意见 | 2026-03-20 | Chinese | ||
| 39253852 | 中信证券股份有限公司关于悦康药业集团股份有限公司部分募投项目变更及结项暨将节余募集资金用于新增募投项目及永久补充流动资金的核查意见 | 2026-03-20 | Chinese | ||
| 39253848 | 2025年度独立董事述职报告（陈可冀）（届满离任） | 2026-03-20 | Chinese | ||
| 39253839 | 2025年度募集资金存放与实际使用情况鉴证报告 | 2026-03-20 | Chinese | ||
| 39253731 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-03-20 | Chinese | ||
| 39253724 | 2025年度独立董事述职报告（王波）（届满离任） | 2026-03-20 | Chinese | ||
| 39253723 | 第三届董事会第四次会议决议公告 | 2026-03-20 | Chinese | ||
| 39253713 | 关于2025年度“提质增效重回报”行动方案的评估报告及2026年度“提质增效重回报”行动方案 | 2026-03-20 | Chinese | ||
| 39253707 | 2025年年度报告 | 2026-03-20 | Chinese | ||
| 39253687 | 2025年度内部控制审计报告 | 2026-03-20 | Chinese | ||
| 39253599 | 中信证券股份有限公司关于悦康药业集团股份有限公司使用暂时闲置募集资金进行现金管理的核查意见 | 2026-03-20 | Chinese | ||
| 39253591 | 关于公司2025年度利润分配预案的公告 | 2026-03-20 | Chinese | ||
| 39253583 | 关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-03-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Youcare Pharmaceutical Group Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58564/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58564 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58564 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58564 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58564}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Youcare Pharmaceutical Group Co.,Ltd. (id: 58564)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.